MeSH term
Frequency | Condition_Probility | Animals | 18 | 0.0 |
Humans | 31 | 0.0 |
Base Sequence | 6 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Chromosomes, Human, Pair 6/*genetics | 2 | 1.0 |
Cornea/*abnormalities | 2 | 66.0 |
*DNA-Binding Proteins | 15 | 0.0 |
Eye Abnormalities/*genetics | 7 | 17.0 |
Female | 16 | 0.0 |
Genotype | 6 | 0.0 |
Glaucoma/*genetics | 5 | 31.0 |
Iris/*abnormalities | 7 | 50.0 |
Male | 12 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Pedigree | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
Abnormalities, Multiple/*genetics | 2 | 0.0 |
Homeodomain Proteins/genetics | 4 | 1.0 |
Mice | 8 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Chromosomes, Human, Pair 4/genetics | 2 | 2.0 |
Chromosomes, Human, Pair 6/genetics | 2 | 1.0 |
DNA Mutational Analysis | 7 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Eye Abnormalities/ethnology/*genetics | 2 | 100.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
Mutation | 5 | 0.0 |
Syndrome | 7 | 0.0 |
Transcription Factors/*genetics | 11 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
COS Cells | 4 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Hela Cells | 5 | 0.0 |
Mutagenesis | 2 | 0.0 |
Phenotype | 8 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Trans-Activation (Genetics) | 5 | 0.0 |
Adolescent | 4 | 0.0 |
Anterior Eye Segment/*abnormalities | 6 | 40.0 |
Child | 4 | 0.0 |
Infant | 5 | 0.0 |
Intraocular Pressure | 2 | 7.0 |
*Mutation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Gene Expression | 2 | 0.0 |
Rats | 2 | 0.0 |
Aged | 3 | 0.0 |
Middle Aged | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Cell Nucleus/chemistry | 2 | 1.0 |
Models, Molecular | 4 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
*Mutation, Missense | 3 | 0.0 |
Protein Conformation | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Transcription Factors/*chemistry/*genetics/metabolism | 2 | 25.0 |
Anterior Chamber/*abnormalities | 2 | 40.0 |
Cercopithecus aethiops | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Plasmids | 2 | 0.0 |
DNA-Binding Proteins/*genetics/physiology | 3 | 3.0 |
Glaucoma/genetics | 2 | 22.0 |
Haplotypes | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Intraocular Pressure/genetics | 3 | 75.0 |
Mice, Mutant Strains | 3 | 0.0 |
Transcription Factors/*genetics/physiology | 4 | 4.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
Pregnancy | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Adult | 7 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Eye Abnormalities/genetics | 2 | 7.0 |
Anterior Eye Segment/*abnormalities/pathology | 2 | 100.0 |
Disease Models, Animal | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
